These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 8501843)

  • 1. Prevalence of high blood cholesterol among US adults. An update based on guidelines from the second report of the National Cholesterol Education Program Adult Treatment Panel.
    Sempos CT; Cleeman JI; Carroll MD; Johnson CL; Bachorik PS; Gordon DJ; Burt VL; Briefel RR; Brown CD; Lippel K
    JAMA; 1993 Jun; 269(23):3009-14. PubMed ID: 8501843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vital signs: prevalence, treatment, and control of high levels of low-density lipoprotein cholesterol--United States, 1999-2002 and 2005-200.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2011 Feb; 60(4):109-14. PubMed ID: 21293326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of evidence-based "clinical judgment" on the number of American adults requiring lipid-lowering therapy based on updated NHANES III data. National Health and Nutrition Examination Survey.
    Jacobson TA; Griffiths GG; Varas C; Gause D; Sung JC; Ballantyne CM
    Arch Intern Med; 2000 May; 160(9):1361-9. PubMed ID: 10809042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in high levels of low-density lipoprotein cholesterol in the United States, 1999-2006.
    Kuklina EV; Yoon PW; Keenan NL
    JAMA; 2009 Nov; 302(19):2104-10. PubMed ID: 19920234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment patterns and distribution of low-density lipoprotein cholesterol levels in treatment-eligible United States adults.
    Hoerger TJ; Bala MV; Bray JW; Wilcosky TC; LaRosa J
    Am J Cardiol; 1998 Jul; 82(1):61-5. PubMed ID: 9671010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in ATP-III-defined high blood cholesterol prevalence, awareness, treatment and control among U.S. adults.
    Hyre AD; Muntner P; Menke A; Raggi P; He J
    Ann Epidemiol; 2007 Jul; 17(7):548-55. PubMed ID: 17395483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eligibility for cholesterol referral in community-dwelling older adults. The Cardiovascular Health Study.
    Manolio TA; Furberg CD; Wahl PW; Tracy RP; Borhani NO; Gardin JM; Fried LP; O'Leary DH; Kuller LH
    Ann Intern Med; 1992 Apr; 116(8):641-9. PubMed ID: 1546864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in statin use and low-density lipoprotein cholesterol levels among US adults: impact of the 2001 National Cholesterol Education Program guidelines.
    Mann D; Reynolds K; Smith D; Muntner P
    Ann Pharmacother; 2008 Sep; 42(9):1208-15. PubMed ID: 18648016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of hypercholesterolemia among siblings of persons with premature coronary heart disease. Application of the Second Adult Treatment Panel guidelines.
    Allen JK; Young DR; Blumenthal RS; Moy TF; Yanek LR; Wilder L; Becker LC; Becker DM
    Arch Intern Med; 1996 Aug 12-26; 156(15):1654-60. PubMed ID: 8694663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential effects of reclassifying CKD as a coronary heart disease risk equivalent in the US population.
    Foster MC; Rawlings AM; Marrett E; Neff D; Grams ME; Kasiske BL; Willis K; Inker LA; Coresh J; Selvin E
    Am J Kidney Dis; 2014 May; 63(5):753-60. PubMed ID: 24369751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in serum lipids and lipoproteins of adults, 1960-2002.
    Carroll MD; Lacher DA; Sorlie PD; Cleeman JI; Gordon DJ; Wolz M; Grundy SM; Johnson CL
    JAMA; 2005 Oct; 294(14):1773-81. PubMed ID: 16219880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prevalence of high blood cholesterol levels among adults in the United States.
    Sempos C; Fulwood R; Haines C; Carroll M; Anda R; Williamson DF; Remington P; Cleeman J
    JAMA; 1989 Jul; 262(1):45-52. PubMed ID: 2733124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of lipid abnormalities in the United States: the National Health and Nutrition Examination Survey 2003-2006.
    Tóth PP; Potter D; Ming EE
    J Clin Lipidol; 2012; 6(4):325-30. PubMed ID: 22836069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New National Cholesterol Education Program III guidelines for primary prevention lipid-lowering drug therapy: projected impact on the size, sex, and age distribution of the treatment-eligible population.
    Fedder DO; Koro CE; L'Italien GJ
    Circulation; 2002 Jan; 105(2):152-6. PubMed ID: 11790693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum cholesterol concentration and prevalence, awareness, treatment, and control of high low-density lipoprotein cholesterol in the Korea National Health and Nutrition Examination Surveys 2008-2010: Beyond the Tip of the Iceberg.
    Lee YH; Lee SG; Lee MH; Kim JH; Lee BW; Kang ES; Lee HC; Cha BS
    J Am Heart Assoc; 2014 Feb; 3(1):e000650. PubMed ID: 24572249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum total cholesterol concentrations and awareness, treatment, and control of hypercholesterolemia among US adults: findings from the National Health and Nutrition Examination Survey, 1999 to 2000.
    Ford ES; Mokdad AH; Giles WH; Mensah GA
    Circulation; 2003 May; 107(17):2185-9. PubMed ID: 12719276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic lifestyle changes and drug treatment for high blood cholesterol in China and application of the Adult Treatment Panel III guidelines.
    Muntner P; Gu D; Reynolds RF; Wu X; Chen J; Whelton PK; He J
    Am J Cardiol; 2005 Nov; 96(9):1260-5. PubMed ID: 16253594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AMG 145, a monoclonal antibody against PCSK9, facilitates achievement of national cholesterol education program-adult treatment panel III low-density lipoprotein cholesterol goals among high-risk patients: an analysis from the LAPLACE-TIMI 57 trial (LDL-C assessment with PCSK9 monoclonal antibody inhibition combined with statin thErapy-thrombolysis in myocardial infarction 57).
    Desai NR; Giugliano RP; Zhou J; Kohli P; Somaratne R; Hoffman E; Liu T; Scott R; Wasserman SM; Sabatine MS
    J Am Coll Cardiol; 2014 Feb; 63(5):430-3. PubMed ID: 24161333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of Pediatric and Adult Guidelines for Treatment of Lipid Levels Among US Adolescents Transitioning to Young Adulthood.
    Gooding HC; Rodday AM; Wong JB; Gillman MW; Lloyd-Jones DM; Leslie LK; de Ferranti SD
    JAMA Pediatr; 2015 Jun; 169(6):569-74. PubMed ID: 25845026
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.